News

Johnson & Johnson expands Covid-19 vaccine trial to adolescents – Clinical Trials Arena

Johnson & Johnson (J&J) has expanded Phase IIa clinical trial of Covid-19 vaccine candidate to include adolescent subjects aged 12 to 17 years.

Info This site is a curated archive of articles with a link to the source. Keywords and topics covered in the publication can be found above. Click on the tag to view a listing of similar articles.
Links Are any links broken? The page may have been taken down. Visit archive.is or archive.org to view the archive snapshot.
Links Help fight censorship and preserve information on the internet. Archive this source and links on archive.is and archive.org. Save a local copy on your own hard drive.